Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2026)
Hims & Hers Health (HIMS) reported EBITDA Margin of 12.88% for Q1 2026, down 2276.0% on a YoY basis from 0.59% in Q1 2025, and down 966.25% sequentially from 1.49% in Q4 2025.
Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of EBITDA Margin data on file, last reported at 12.88% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 2276.0% year-over-year to 12.88%; the trailing twelve-month figure through Mar 2026 stood at 1.29% (down 745.0% YoY), and the FY2025 full-year result was 4.5%, up 31.0% from the prior year.
- EBITDA Margin retreated to 12.88% in Q1 2026, from 1.49% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9.88% in Q1 2025 to a low of 17.78% in Q2 2022.
- A 5-year average of 2.8% and a median of 0.16% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin jumped 7584 bps in 2022 and plunged 2276 bps in 2026, its largest moves.
- Tracing HIMS's EBITDA Margin over 5 years: stood at 6.94% in 2022, then surged by 98 bps to 0.16% in 2023, then jumped by 2483 bps to 3.86% in 2024, then slumped by 62 bps to 1.49% in 2025, then tumbled by 966 bps to 12.88% in 2026.
- Business Quant data shows HIMS's EBITDA Margin at 12.88% in Q1 2026, 1.49% in Q4 2025, and 1.97% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 41.69% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 21.23% |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -12.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.88% |
| Dec 31, 2025 | 1.49% |
| Sep 30, 2025 | 1.97% |
| Jun 30, 2025 | 4.90% |
| Mar 31, 2025 | 9.88% |
| Dec 31, 2024 | 3.86% |
| Sep 30, 2024 | 5.57% |
| Jun 30, 2024 | 3.49% |
| Mar 31, 2024 | 3.56% |
| Dec 31, 2023 | -0.16% |
| Sep 30, 2023 | -3.77% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -5.90% |
| Dec 31, 2022 | -6.94% |
| Sep 30, 2022 | -13.80% |
| Jun 30, 2022 | -17.78% |
| Mar 31, 2022 | -16.70% |
| Dec 31, 2021 | -25.46% |
| Sep 30, 2021 | -37.29% |
| Jun 30, 2021 | -28.68% |